1275. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains written procedures governing approval authority for treatment abroad scheme applications by staff grade or management level. [39171/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
1276. Deputy Ken O'Flynn asked the Minister for Health whether all treatment abroad scheme approvals are processed solely within the National Treatment Abroad Office in Kilkenny; and if not, the circumstances under which applications are referred elsewhere within the HSE. [39172/26]
1277. Deputy Ken O'Flynn asked the Minister for Health whether the HSE applies different governance or oversight procedures to Treatment Abroad Scheme applications involving experimental, highly specialised or unusually costly procedures. [39173/26]
1278. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has established any expenditure cap, annual limit or financial-control mechanism applicable to individual treatment abroad scheme referrals. [39174/26]
1279. Deputy Ken O'Flynn asked the Minister for Health the dates on which the treatment abroad scheme was last audited by the HSE Internal Audit Office and by the Comptroller and Auditor General respectively; whether any findings, recommendations or corrective actions arose from those audits; and if she will make a statement on the matter. [39181/26]
1280. Deputy Ken O'Flynn asked the Minister for Health whether any dedicated value-for-money review has been conducted in relation to the treatment abroad scheme since 2020; and if so, to provide details of the review, its conclusions and any resulting policy changes. [39182/26]
1281. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health maintains a formal risk register relating to the treatment abroad scheme; and if so, the categories of risk monitored including financial, clinical, governance and patient safety risks. [39183/26]
1282. Deputy Ken O'Flynn asked the Minister for Health whether any external clinical governance framework exists for treatments funded under the treatment abroad scheme; and if not, whether consideration is being given to establishing such a framework. [39184/26]
1283. Deputy Ken O'Flynn asked the Minister for Health whether the quarterly oversight meetings between the treatment abroad scheme and the Department of Health produce formal minutes, action logs or governance reports; and whether these documents are retained centrally by the Department. [39185/26]
1284. Deputy Ken O'Flynn asked the Minister for Health whether the Department has examined the establishment of an independent oversight or inspection mechanism for the treatment abroad scheme, comparable to governance arrangements applying in other areas of publicly funded healthcare expenditure. [39186/26]
1285. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken regarding the appropriateness of relying primarily on referring consultants for overseas treatment selection and governance assurance under the treatment abroad scheme. [39187/26]
1286. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the treatment abroad scheme for each year from 2020 to 2026, inclusive, and the proportion of that expenditure subject to formal audit review. [39188/26]
1287. Deputy Ken O'Flynn asked the Minister for Health whether the HSE conducts any comparative benchmarking of treatment costs between different EU or EEA jurisdictions under the treatment abroad scheme; and if she will provide details of the methodology used. [39189/26]
1288. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme for procedures not currently available in Ireland. [39190/26]
1289. Deputy Ken O'Flynn asked the Minister for Health whether any central register exists recording the total annual cost per treatment category funded under the treatment abroad scheme. [39191/26]
1290. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records clinical outcomes, complication rates or patient satisfaction data in respect of procedures funded under the treatment abroad scheme. [39192/26]
1291. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health has carried out any review assessing whether certain procedures regularly funded abroad under the treatment abroad scheme could be developed domestically within the public health system. [39193/26]
1292. Deputy Ken O'Flynn asked the Minister for Health whether any maximum financial approval thresholds apply under the treatment abroad scheme before additional senior management or Departmental approval is required. [39194/26]
1293. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audit specifically examining value-for-money, expenditure controls or financial governance under the treatment abroad scheme since 2020. [39195/26]
1294. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains data comparing the cost of treatments funded abroad under the treatment abroad scheme against estimated equivalent domestic treatment costs. [39196/26]
1295. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is currently subject to any formal risk assessment relating to expenditure growth, cost escalation, or dependency on overseas treatment provision. [39197/26]
1296. Deputy Ken O'Flynn asked the Minister for Health whether any external consultancy, economic review, or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme since 2020. [39198/26]
1297. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central register of adverse clinical outcomes, complications, revision procedures, hospital readmissions or patient safety incidents arising from treatments funded under the treatment abroad scheme.; and if she will make a statement on the matter. [39199/26]
1298. Deputy Ken O'Flynn asked the Minister for Health whether the HSE receives any routine post-treatment clinical outcome reports from overseas providers in respect of procedures funded under the treatment abroad scheme. [39200/26]
1299. Deputy Ken O'Flynn asked the Minister for Health whether any structured patient follow-up programme exists for persons returning to Ireland following procedures funded under the treatment abroad scheme. [39201/26]